Mankind Pharma Limited (NSE:MANKIND)

Market Cap	1.05T
Revenue (ttm)	129.10B
Net Income (ttm)	18.93B
Shares Out	412.73M
EPS (ttm)	46.42
PE Ratio	54.67
Forward PE	46.95
Dividend	2.00 (0.08%)
Ex-Dividend Date	n/a

Volume	700,548
Average Volume	609,054
Open	2,538.70
Previous Close	2,537.80
Day's Range	2,455.10 - 2,540.00
52-Week Range	2,028.05 - 3,054.80
Beta	0.35
RSI	43.82
Earnings Date	Jul 31, 2025

About Lions Gate Entertainment

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 26,978
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANKIND

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.